Status:
COMPLETED
A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization.
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
COVID-19
Mental Health Impairment
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study presents a digital mental-health protocol designed to offer remote, personalized support to former or current COVID-19 patients. A total of 100 subjects will be enrolled. Participation is ...
Eligibility Criteria
Inclusion
- Age 18-80
- A positive COVID-19 test at the moment of enrolment for subjects in the 'patients' group
- Adequate sensory and motor abilities, without impairments in vision, hearing and handling devices
- Access to Internet wireless technologies.
- A good level of Italian in terms of speaking, reading and writing.
Exclusion
- Present of past medical history of schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder, current substance abuse, all according to the diagnostic and statistical manual fifth edition (DSM-5) (American Psychiatric Association, 2013).
- With a diagnosis of cognitive impairment and/or dementia (e.g., mild cognitive impairment, Alzheimer's disease, Parkinson's disease);
- Intellectual disability defined by a total IQ \< 70 in Test di Intelligenza Breve (TIB) (Sartori et al., 1997) or Standard Progressive Raven Matrices (John \& Raven, 2003)
- Severe present medical conditions that could interfere with participation.
- Present or past suicidal ideation or commitment.
- Significant impairment in the use of digital and technological devices, in questionnaires and test completions, comprehension or with lack of a compliant behavior in the earliest evaluations.
- Being enrolled in other clinical trials assessing any psychological, or experimental pharmacological treatment.
Key Trial Info
Start Date :
October 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05231018
Start Date
October 28 2020
End Date
December 31 2022
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paolo Brambilla
Milan, Italy, Italy, 20100